Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 04 May 2020 for Urovant Sciences Ltd.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Bryan E. Smith: trading record in brief
All filings by Bryan E. Smith on record concern Urovant Sciences Ltd. Over a trading history stretching from 7 January 2020 to 1 May 2020, the count stands at 5 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 4 May 2020, the filings show a share grant in Urovant Sciences Ltd. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Bryan E. Smith
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
77,606 shares0Common SharesSEC:0001209191-20-026841:0
50,000 shares@ US$6.8834.5% of flowCommon SharesSEC:0000899243-20-005516:0
34,835 shares@ US$13.0845.7% of flowCommon SharesSEC:0000899243-20-005516:1
15,165 shares@ US$13.0819.9% of flowCommon SharesSEC:0000899243-20-005516:2
50,000 shares0Common SharesSEC:0000899243-20-000881:0
5 of 5 declarations
